-
Mashup Score: 0
In this interview, Siperstein explained some of the biggest takeaways from her conference presentation on advances in microneedling techniques, including radiofrequency specifically.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
In this interview, Siperstein explained some of the biggest takeaways from her conference presentation on advances in microneedling techniques, including radiofrequency specifically.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In an interview at #AAD2023, Dr. Robyn Siperstein explained some of the biggest takeaways from her presentation microneedling techniques for skin of color. Check out the full interview here: https://t.co/689h3rdIpZ #AAD23 #dermatology
-
-
Mashup Score: 0
In this interview, Siperstein explained some of the biggest takeaways from her conference presentation on advances in microneedling techniques, including radiofrequency specifically.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Dr. Robyn Siperstein described the biggest takeaways from her #AAD2023 presentation on advances in #microneedling techniques, including techniques for skin of color. View the full story here: https://t.co/3xdrXQUVEi #dermatology #AAD23
-
-
Mashup Score: 0
In recently-presented data, ivarmacitinib was found to have decreased severity of moderate-to-severe eczema compared to placebo.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Late breaking data from #AAD23 showed that treatment with ivarmacitinib (8 mg or 4 mg) was well-tolerated/effective in patients aged 12 and over with moderate-to-severe atopic dermatitis. Check out the data here: https://t.co/F44rDq6OVS #AAD2023 #eczema
-
-
Mashup Score: 0
In a conference interview, Cohen delved into the major takeaways covered in his presentation on the latest information related to psoriasis and its therapy.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In an @MDMagazine interview, Cohen delved into the major takeaways covered in his #AAD2023 presentation on the latest information regardng psoriasis comorbidities and different therapies. Check out the interview here: https://t.co/UswPfJWGMq #AAD23 #psoriasis #dermatology
-
-
Mashup Score: 0
New late-breaking data showed that oral roflumilast treatment was both safe and efficacious against psoriasis, making it a potentially less expensive and convenient treatment alternative.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
New late-breaking #AAD23 data showed that oral roflumilast was both safe & efficacious against #psoriasis, making it a potentially less expensive treatment alternative. Check out the trial results here: https://t.co/QtbYFtpmIj #PlaquePsoriasis #AAD2023
-
-
Mashup Score: 1CBP-201 Antibody Found to Decrease Severity of Atopic Dermatitis - 1 year(s) ago
New late-breaking data supported prior results indicating that all primary and secondary endpoints were reached for the IL-4Rα antibody known as CBP-201 for atopic dermatitis patients.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
In data presented at #AAD2023, patients with atopic dermatitis treated with CBP-201 at 16 weeks achieved more significant improvements in IGA, EASI-75, EASI-90, and PP-NRS, than with placebo. Read more on the data here: https://t.co/dnXoVZDb2n #AAD23 #eczema
-
-
Mashup Score: 0
In research drawn from his conference presentation, Lim discussed the unique photoprotection needs of skin of color as well as some of the challenges faced by patients in this population.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Check out another segment from Dr. Henry Lim's interview at #AAD2023, during which he discusses the personalized photoprotection needs of diverse skin types. View the interview here: https://t.co/mjKZPcZwMr #photoprotection #phototherapy #AAD23
-
-
Mashup Score: 0Dermatology | Medical News & Expert Insight | HCPLive - 1 year(s) ago
The dermatology condition center is a comprehensive resource for clinical news and expert insights on dermatology. Read more at HCPLive.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Another informative day kicking off at #AAD2023! Want to learn more about the newest late-breaking data & interviews? Follow @MDMagazine as we continue to cover the conference & share the latest developments in the field! https://t.co/vaU1FF8KGb #AAD23 #dermatology https://t.co/sQbJaYCPLY
-
-
Mashup Score: 0
Kwatra spoke about his team’s research into nemolizumab for prurigo nodularis in the OLYMPIA 2 trial, including the data and its implications for the future.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
An insightful interview at #AAD2023 with @drshawnkwatra on new, late-breaking data regarding nemolizumab monotherapy for prurigo nodularis. Check out the interview here: https://t.co/6XXjeu5XHN #PrurigoNodularis #dermatology #AAD23
-
ICYMI: In this #AAD23 interview, Dr. Robyn Siperstein explained some of the biggest takeaways from her conference presentation on advances in #microneedling techniques, including radiofrequency specifically: https://t.co/y8nSA7dY21